Carregant...
In silico dose prediction for long-acting rilpivirine and cabotegravir administration to children and adolescents
BACKGROUND AND OBJECTIVES: Long-acting injectable (LAI) antiretrovirals (ARVs) represent a pharmacological alternative to oral formulations and an innovative clinical option to address adherence and reduce drug costs. Clinical studies in children and adolescents are characterised by ethical and logi...
Guardat en:
| Publicat a: | Clin Pharmacokinet |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5701864/ https://ncbi.nlm.nih.gov/pubmed/28540638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-017-0557-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|